TARA compared with RLMD: revenue, margins and what each company keeps, and the suppliers and customers both name

TARAProtara Therapeutics, Inc.

Mkt capRevenueRevenue

RLMDRelmada Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

TARAProtara Therapeutics, Inc.

RLMDRelmada Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TARA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±26.9%▲+7.98%×0.30

Q2 FY26±21.5%▼−4.87%×0.23

May 13 '26±13.2%▲+0.97%×0.08

Q1 FY26±17.9%▼−0.70%×0.04

RLMD1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.8%▼−8.01%×0.63

= impliedTARA realized, solidRLMD realized, hatchedOne scale, both sides: full bar = 27%× = |realized| ÷ impliedSource: market data

TARAProtara Therapeutics, Inc.

2.28▲+7.04%· post 2.28

Mkt cap$144.6M

RLMDRelmada Therapeutics, Inc.

3.91▲+3.58%· post 3.91

ClosedNov 6 '26

Mkt cap$438.3M

Compare

ClosedNov 6 '26

TARAProtara Therapeutics, Inc.

RLMDRelmada Therapeutics, Inc.

2.28▲+7.04%post 2.28

Price

3.91▲+3.58%post 3.91

$144.6M

Mkt cap

$438.3M

TARA2.28▲+7.04%vsRLMD3.91▲+3.58%ClosedNov 6 '26